Approval for Incorporation of Subsidiary in the Philippines and Investment by way of Subscription to its Equity Share Capital is attached herewith.

Filed: 14 Aug 2026, 20:05 IST Exchange: BSE Category: Merger/Acquisition — Subsidiary Incorporation

Approval for incorporation of a subsidiary in the Philippines and investment by cash subscription to its equity share capital. - Proposed entity: Gufic Philippines Inc., to be incorporated within 12 months - Industry: Pharmaceuticals, focusing on marketing, sale, distribution, and IP management in the Philippines - Investment up to USD 250,000 or equivalent in PHP - Gufic Biosciences to hold approx. 99.99% equity and control - Subject to regulatory approvals including SEC Philippines and pharmaceutical licenses

Source: Original filing PDF — view on exchange portal

⚡ You're reading this after the fact — subscribers got it instantly

ISA

Indian Stock Alerts BOT

🚨 GUFICBIO — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add GUFICBIO to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

More on Gufic Biosciences Limited

Important. The summary above is generated automatically from Gufic Biosciences Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.